Identification and characterization of a novel enhancer for the human MCT-1 oncogene promoter
✍ Scribed by Bo Shi; Victor Levenson; Ronald B. Gartenhaus
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 438 KB
- Volume
- 90
- Category
- Article
- ISSN
- 0730-2312
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Cloning and characterization of the promoter region for the MCT‐1 oncogene is described. We used luciferase assays to identify cis‐acting elements responsible for human MCT‐1 promoter function. The MCT‐1 promoter is TATA‐less with a consensus initiator element located at the transcription start site and facilitated by two Sp1 sites that directs basal transcription. Deletion of a region of the MCT‐1 promoter (−133 to −122) resulted in significant decrease in luciferase activity, suggesting that this region contains a positive cis‐acting element. Using mobility shift assays with a 26‐mer oligonucleotide, which contains this fragment and its flanking regions, we demonstrated the presence of sequence‐specific DNA‐binding protein in both Jurkat and Hela nuclear extracts that we designated as LMBF (for lymphoid MCT‐1 binding factor). This 26‐mer oligonucleotide containing the LMBF binding site is required for maximum transcriptional activity of the MCT‐1 promoter. Although the 26‐mer oligonucleotide contains a sequence with strong homology to a heat‐shock factor consensus, competitive electrophoretic mobility shift assay (EMSA) analysis demonstrated that the binding protein is not a known member of heat shock family. Furthermore, this sequence when placed in reverse orientation downstream of the luciferase gene was able to enhance luciferase activity driven by a minimal promoter. These data are consistent with this sequence behaving as an enhancer. Finally, Southwestern blot analysis revealed a 96‐kDa protein capable of binding a probe containing the LMBF binding site. J. Cell. Biochem. 90: 68–79, 2003. © 2003 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
We studied 20 unrelated NF1 patients by Southern blots with seven cDNA probes and loss of heterozygosity (LOH) analysis with four intragenic microsatellites (IVS26-2.3, IVS27AC28.4, IVS27AC33.1, and IVS38GT53.0). Four novel large deletions (178, 184, 236, and 237) have been identified and characteri
## Abstract Distant metastasis is a major factor associated with poor prognosis in head and neck squamous cell carcinomas (HNSCC), but little is known of its molecular mechanisms. New markers that predict clinical outcome, in particular the ability of primary tumors to develop metastatic tumors, ar
Northern blot and RT-PCR analyses indicated that the human papillomavirus E4 open reading frame is expressed in HeLa cells. Because integration at the E1 or E2 open reading frame would place the viral upstream regulatory region downstream of the viral late genes, the expression of E4 in HeLa cells i
The incubation of oxymetazoline, a nonprescription nasal decongestant, with human liver microsomes (HLMs) supplemented with uridine-5-diphosphoglucuronic acid (UDPGA) generated glucuronide metabolite as observed by LC/MS/MS. The uridine glucuronosyltransferases (UGTs) responsible for the O-glucuroni
## Abstract Voltage‐gated sodium channels play critical roles in the excitability of the brain. A decreased level of Na~v~1.1 has been identified as the cause of severe myoclonic epilepsy in infancy. In the present study, we identified the transcription start site and three 5′‐untranslated exons of